Literature DB >> 14647274

Evidence from the generation of immunoglobulin G-secreting cells that stochastic mechanisms regulate lymphocyte differentiation.

Jhagvaral Hasbold1, Lynn M Corcoran, David M Tarlinton, Stuart G Tangye, Philip D Hodgkin.   

Abstract

Naive B lymphocytes undergo isotype switching and develop into immunoglobulin-secreting cells to generate the appropriate class and amount of antibody necessary for effective immunity. Although this seems complex, we report here that the generation of immunoglobulin G-secreting cells from naive precursors is highly predictable. The probabilities of isotype switching and development into secreting cells change with successive cell divisions and interleave independently. Cytokines alter the probability of each differentiation event, while leaving intact their independent assortment. As a result, cellular heterogeneity arises automatically as the cells divide. Stochastic division-linked regulation of heterogeneity challenges the conventional paradigms linking distinct phenotypes to unique combinations of signals and has the potential to simplify our concept of immune complexity considerably.

Mesh:

Substances:

Year:  2003        PMID: 14647274     DOI: 10.1038/ni1016

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  96 in total

Review 1.  Divide and conquer: the importance of cell division in regulating B-cell responses.

Authors:  Stuart G Tangye; Philip D Hodgkin
Journal:  Immunology       Date:  2004-08       Impact factor: 7.397

Review 2.  Control systems and decision making for antibody production.

Authors:  Christopher C Goodnow; Carola G Vinuesa; Katrina L Randall; Fabienne Mackay; Robert Brink
Journal:  Nat Immunol       Date:  2010-07-20       Impact factor: 25.606

3.  In vitro induction of immunoglobulin A (IgA)- and IgM-secreting plasma blasts by cholera toxin depends on T-cell help and is mediated by CD154 up-regulation and inhibition of gamma interferon synthesis.

Authors:  Sergio Arce; Hesham F Nawar; Gwendolin Muehlinghaus; Michael W Russell; Terry D Connell
Journal:  Infect Immun       Date:  2007-01-12       Impact factor: 3.441

4.  A model of immune regulation as a consequence of randomized lymphocyte division and death times.

Authors:  E D Hawkins; M L Turner; M R Dowling; C van Gend; P D Hodgkin
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-14       Impact factor: 11.205

5.  Search for quantitative trait loci of atopy-associated immune responses using allergen-specific IgG1 as an "endophenotype".

Authors:  Duaine R Jackola; Michael B Miller; Carol L Liebeler; Malcolm N Blumenthal
Journal:  Hum Immunol       Date:  2007-09-07       Impact factor: 2.850

6.  Plasma cell-specific transcription factor XBP-1s binds to and transactivates the Epstein-Barr virus BZLF1 promoter.

Authors:  Chia Chi Sun; David A Thorley-Lawson
Journal:  J Virol       Date:  2007-09-26       Impact factor: 5.103

7.  Inhibition of cyclooxygenase-2 impairs the expression of essential plasma cell transcription factors and human B-lymphocyte differentiation.

Authors:  Matthew P Bernard; Richard P Phipps
Journal:  Immunology       Date:  2010-01       Impact factor: 7.397

8.  A single-cell pedigree analysis of alternative stochastic lymphocyte fates.

Authors:  E D Hawkins; J F Markham; L P McGuinness; P D Hodgkin
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-24       Impact factor: 11.205

9.  PD-1 regulates germinal center B cell survival and the formation and affinity of long-lived plasma cells.

Authors:  Kim L Good-Jacobson; Courtney G Szumilas; Lieping Chen; Arlene H Sharpe; Mary M Tomayko; Mark J Shlomchik
Journal:  Nat Immunol       Date:  2010-05-09       Impact factor: 25.606

10.  A pilot study of the immune response to whole inactivated avian influenza H7N1 virus vaccine in mice.

Authors:  Arnt-Ove Hovden; Karl A Brokstad; Diane Major; John Wood; Lars R Haaheim; Rebecca J Cox
Journal:  Influenza Other Respir Viruses       Date:  2009-01       Impact factor: 4.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.